Literature DB >> 8337697

Apoptosis: a product of programmed and unprogrammed cell death.

A Eastman1.   

Abstract

Apoptosis is a form of cell death defined by morphological and biochemical characteristics. Although originally described in 1972, it is only very recently that significant interest in the subject has occurred, possibly as a result of the identification of genes that may either positively or negatively regulate the process. With the rapid expansion of knowledge, it has become apparent that there are multiple pathways that induce apoptosis; some of these may represent programmed events but others are clearly unprogrammed. To clarify the terminology used, it is recommended that apoptosis be used as originally defined to refer only to the end product of these pathways. Furthermore, the realization that a cell can die by multiple pathways suggests caution when translating experimental results. Many potential intermediates may be identified but they may represent components of different pathways. Concern for the use of various inhibitors of apoptosis is also presented. Future directions will be aimed at the definitive identification of the signal mechanisms regulating apoptotic cell death.

Mesh:

Substances:

Year:  1993        PMID: 8337697     DOI: 10.1006/taap.1993.1141

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-X(L) and Mcl-1 expressing human cholangiocarcinoma cells.

Authors:  A C Okaro; D A Fennell; M Corbo; B R Davidson; F E Cotter
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

2.  A small inhibitor of the interaction between Bax and Bcl-X(L) can synergize with methylprednisolone to induce apoptosis in Bcl-X(L)-overexpressing breast-cancer cells.

Authors:  Yee-Joo Tan; Eileen Teng; Anthony E Ting
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-16       Impact factor: 4.553

3.  Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.

Authors:  S A Holden; B A Teicher; M F Robinson; D Northey; A Rosowsky
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  Induction of Apoptosis in Rat Peripheral Blood Lymphocytes by the Anticancer Drug CI-994 (Acetyldinaline)(*).

Authors:  Michael J. Graziano; Teresa A. Spoon; Erin A. Cockrell; Paul E. Rowse; Andrea J. Gonzales
Journal:  J Biomed Biotechnol       Date:  2001

5.  The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice - implications for cancer therapy.

Authors:  Ricardo A Chaurio; Luis E Muñoz; Christian Maueröder; Christina Janko; Thomas Harrer; Barbara G Fürnrohr; Michael Niederweis; Rostyslav Bilyy; Georg Schett; Martin Herrmann; Christian Berens
Journal:  Front Immunol       Date:  2014-11-11       Impact factor: 7.561

6.  Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.

Authors:  H Nakata; Y Kikuchi; T Tode; J Hirata; T Kita; K Ishii; K Kudoh; I Nagata; N Shinomiya
Journal:  Jpn J Cancer Res       Date:  1998-07

7.  Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression.

Authors:  A C Wood; P Elvin; J A Hickman
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.